2021-06-24T07:50:58-05:00 2020-12-31 382706146 YEO & YEO PC 1450 EISENHOWER PLACE ANN ARBOR MI 481083283 990 2020-01-01 382117115 EVERSIGHT EVER 8002477250 3985 RESEARCH PARK DR ANN ARBOR MI 48108 DIANE HOLLINGSWORTH PRESIDENT & CEO 8002477250 2021-06-21 true DIANE HOLLINGSWORTH 999009999 BRIAN R DIXON P01321580 7347691331 2021-06-21 2020 2022-09-23 18:48:47Z DIANE HOLLINGSWORTH 26663962 false X WWW.EVERSIGHTVISION.ORG X 1986 MI EVERSIGHT IS A 501(C)3 NONPROFIT ORGANIZATION WITH THE MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. THE EVERSIGHT NETWORK IS RESPONSIBLE FOR RECOVERING, EVALUATING AND PROVIDING HUMAN EYE TISSUE FOR TRANSPLANTATION; ADVANCING RESEARCH INTO THE CAUSES AND CURES OF BLINDING EYE CONDITIONS; PROMOTING DONATION AWARENESS THROUGH PUBLIC AND PROFESSIONAL EDUCATION; AND PROVIDING HUMANITARIAN AID TO PEOPLE AROUND THE WORLD IN NEED OF CORNEAL TRANSPLANTATION. FOUNDED IN 1947, EVERSIGHT MAINTAINS ITS COMMITMENT TO EXCELLENCE AS AN ACCREDITED MEMBER OF THE EYE BANK ASSOCIATION OF AMERICA (EBAA) AND BY MEETING THE HIGHEST QUALITY STANDARDS SET BY THE U.S. FOOD AND DRUG ADMINISTRATION. THE NONPROFIT OPERATES 24/7/365 IN CONNECTICUT, ILLINOIS, MICHIGAN, NEW JERSEY, OHIO AND SOUTH KOREA, AND COLLABORATES WITH SURGEONS, RESEARCHERS, ACADEMIC MEDICAL CENTERS AND EYE BANKS ACROSS THE UNITED STATES AND ABROAD. EVERSIGHT WORKS WITH THE 11 11 176 124 0 1197972 672370 21313494 19849742 511589 453662 -144883 21345 22878172 20997119 0 0 11536515 10918716 0 641265 10136975 9554849 21673490 20473565 1204682 523554 33975355 36782737 20882096 22450700 13093259 14332037 X EVERSIGHT'S MISSION IS TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. BLINDING EYE DISEASES AFFECT 80 MILLION AMERICANS. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, DRIVE TO WORK OR READ THE NEWSPAPER ON A SUNDAY MORNING. THEIR VISION LOSS RESULTS IN AN ECONOMIC IMPACT OF 51.4 BILLION EVERY YEAR IN THE UNITED STATES ALONE. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL MOTHERS CAN SEE THEIR CHILDREN AND ALL CHILDREN CAN GROW UP TO LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. TO MAKE VISION A REALITY FOR ALL, EVERSIGHT CONTINUOUSLY WORKS TO EXPAND ITS REACH, CONNECT MORE EFFECTIVELY WITH COMMUNITIES IN NEED AND PROVIDE THE GIFT OF SIGHT TO EVERYONE. false false 9561912 18207612 RESORING SIGHT IN 2020, EVERSIGHT PROVIDED THE GIFT OF SIGHT TO MORE THAN 6,500 PEOPLE ACROSS THE UNITED STATES AND AROUND THE WORLD. EVERSIGHT'S WORK BEGAN IN 1947 WITH THE ESTABLISHMENT OF THE FOURTH EYE BANK IN THE UNITED STATES, THEN KNOWN AS THE ILLINOIS EYE-BANK. OVER TIME, NONPROFIT EYE BANKS WERE ESTABLISHED IN EVERY STATE TO MEET THE CRITICAL DEMAND FOR CORNEAL TISSUE TO TREAT PREVENTABLE BLINDNESS. IN 1985, THE ILLINOIS EYE-BANK AND MICHIGAN EYE-BANK FORMED A PARTNERSHIP- ONE THAT WOULD EARN A REPUTATION FOR CLINICAL EXCELLENCE MADE POSSIBLE BY SOME OF THE FINEST MEDICAL DIRECTORS, STAFF AND BOARD MEMBERS IN THE EYE BANKING FIELD. THE SUCCESS OF THE ORGANIZATION ATTRACTED AFFILIATIONS WITH OTHER REGIONAL EYE BANKS FORMING ONE OF THE LARGEST NETWORKS OF EYE BANKS IN THE U.S. IN 2015, THE NETWORK BECAME KNOWN AS EVERSIGHT, ALL WORKING TOGETHER AS A UNIFIED OPERATION TO DELIVER THE HIGHEST QUALITY SERVICES TO SURGEONS AND THEIR PATIENTS AND TO CONTINUE TO GROW OUR IMPACT AROUND THE WORLD. EVERSIGHT FACED CHALLENGES IN 2020 AND SAW THEM THROUGH TO SERVE OUR SURGEONS, THEIR PATIENTS AND DONOR FAMILIES. ON MARCH 18, 2020, U.S. CORNEA TRANSPLANTS WERE IMMEDIATELY HALTED DUE TO THE PANDEMIC. NO ONE KNEW HOW LONG IT WOULD LAST, BUT WITH SACRIFICE, INNOVATION AND STEADFAST DETERMINATION, WE KEPT HOPE IN SIGHT. AS THE VIRUS RAPIDLY SPREAD, NO ONE KNEW WHEN TRANSPLANTS MIGHT RESUME AND THE FINANCIAL IMPACT WAS IMMEDIATE. PROVIDING FOR CORNEA TRANSPLANTATION ACCOUNTS FOR 94 PERCENT OF EVERSIGHT'S OPERATING REVENUE, AND LIKE MANY NONPROFITS, WE CANCELED FUNDRAISERS WE COUNT ON TO SUPPORT OUR WORK. THAT INCLUDED OUR ANNUAL GALA, OUR LARGEST ANNUAL FUNDRAISER TO HELP LOW-INCOME PATIENTS. MEANWHILE, THE PANDEMIC WAS ELIMINATING JOBS AND HEALTH INSURANCE COVERAGE AT HISTORIC RATES ACROSS THE COUNTRY. EVEN WITH NO REVENUE COMING IN, WE DEVELOPED NEW PROTOCOLS, TESTING, TRAINING AND READINESS TO MEET THE DEMAND ONCE TRANSPLANTS COULD RESUME. IN JUNE 2020, WE WENT ABOVE AND BEYOND REGULATORY GUIDANCE AND BEGAN TESTING POTENTIAL SURGICAL TISSUE DONORS FOR SARS-COV-2. THE TEAM'S EXPERTISE AND OUR RIGOROUS STANDARDS HELPED ENSURE PATIENT SAFETY AND THE SAFETY OF DONORS' GIFTS OF TISSUE FOR TRANSPLANTATION, ONCE TRANSPLANTS COULD RESUME. IN THIS NEW PHYSICALLY DISTANCED WORLD, WE QUICKLY DEVELOPED AND BEGAN OFFERING VIRTUAL WEBINARS TO HELP SURGEONS STAY ON TOP OF EVOLVING TECHNOLOGY AND COVID-19 SCIENCE AND SAFETY. EVERSIGHT BECAME THE FIRST EYE BANK TO DEVELOP VIRTUAL WET LAB TRAINING FOR SURGEONS TO PRACTICE THEIR SURGICAL TECHNIQUES. WE PROVIDED THE TECHNOLOGY FOR SURGEONS-WHEREVER THEY ARE IN THE WORLD-TO COME TOGETHER ONLINE AND PRACTICE WITH INDIVIDUALIZED REAL-TIME GUIDANCE FROM LEADING SURGEON INSTRUCTORS. MORE THAN 640 SURGEONS AND OTHER CLINICIANS RECEIVED TRAINING THROUGH EVERSIGHT IN 2020, MORE THAN DOUBLING OUR IMPACT OVER ANY PRIOR YEAR. 1036072 442060 FINDING A CURE IN THE PURSUIT TO ELIMINATE BLINDING EYE DISEASES, EVERSIGHT ESTABLISHED THE EVERSIGHT CENTER FOR VISION AND EYE BANKING RESEARCH IN CLEVELAND, OHIO, TO PROVIDE LEADING OPHTHALMOLOGY RESEARCHERS WITH THE RESOURCES THEY NEED TO FIND CURES AND TREATMENTS FOR EYE DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND GLAUCOMA. EVERSIGHT PROVIDED MORE THAN 2,600 TISSUES FOR RESEARCH AND EDUCATION PURPOSES IN 2020. OUR IN-HOUSE RESEARCH TEAM ALSO PROVIDED EVERSIGHT PARTNERS WITH VALUABLE RESEARCH AND DEVELOPMENT SERVICES, AND PIONEERED NEW EYE BANKING PRACTICES, INCLUDING CRITICAL CLINICAL ADAPTATIONS FOR TISSUE SAFETY DURING THE PANDEMIC. OUR RESEARCH AND CLINICAL LEADERSHIP AND STAFF ARE HIGHLY INVOLVED PRIMARY AND CO-INVESTIGATORS, PERFORMING RESEARCH AND AUTHORING PUBLICATIONS THAT EXPAND THE BOUNDARIES OF VISION SCIENCE, KNOWLEDGE AND POSSIBILITY. EVERSIGHT PRODUCED THE RESEARCH THE WORLD NEEDED IN 2020, INVESTIGATING IF SARS-COV-2 IS PRESENT IN EYE TISSUE. OUR WORK TOOK PLACE IN CLEVELAND, CHICAGO, ANN ARBOR AND IN NEW JERSEY-ALL HEAVILY IMPACTED BY COVID-19-WITH RESEARCH PARTNERS AT CHICAGO CORNEA CONSULTANTS AND RUSH UNIVERSITY, KELLOGG EYE CENTER AND THE UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, AND WAYNE STATE UNIVERSITY. BY OCTOBER 2020, OUR FINDINGS SHOWED A SMALL BUT NOTEWORTHY PREVALENCE OF SARS-COV-2 IN OCULAR TISSUES FROM INDIVIDUALS WHO DIED FROM COVID-19. OUR RESEARCH CONTINUES FOR ALL THOSE IN NEED OF SAFE SIGHT-RESTORING TRANSPLANTS AND FOR ALL THOSE AWAITING A CURE FOR NON- CORNEAL BLINDNESS. EVERSIGHT HAS A LONGSTANDING TRACK RECORD OF RESEARCH AND DEVELOPMENT, TO DATE AWARDING MORE THAN 4 MILLION IN GRANTS THAT STIMULATE PIONEERING CLINICAL AND BASIC SCIENCE RESEARCH AIMING TO DEVELOP NEW WAYS TO RESTORE SIGHT, PREVENT BLINDNESS AND ULTIMATELY HELP PATIENTS LIVE LIFE TO THE FULLEST. SINCE 1980, OUR EYE & VISION RESEARCH GRANT PROGRAM HAS SUPPORTED RESEARCHERS AT LEADING ACADEMIC MEDICAL INSTITUTIONS INCLUDING HARVARD, TUFTS, CLEVELAND CLINIC, CASE WESTERN RESERVE, UNIVERSITY OF MICHIGAN, NORTHWESTERN AND MORE. BY DESIGN, EVERSIGHT'S GRANT PROGRAM PROVIDES CRITICAL, EARLY-STAGE FUNDING THAT IS INTENDED TO DRIVE FOUNDATIONAL RESEARCH AND DISCOVERY. MANY OF THESE PROJECTS HAVE STIMULATED LARGER-SCALE STUDIES AND WON FURTHER FINANCIAL SUPPORT FROM THE NATIONAL INSTITUTES OF HEALTH. IN THE 2020-2021 FUNDING CYCLE, EVERSIGHT AWARDED GRANTS TO ADVANCE STUDIES ON TRANSPLANT GRAFT REJECTION, SARS-COV-2 AND THE EYE, FUCHS DYSTROPHY, DRY EYE AND NOVEL CORNEA THERAPIES, LED BY RESEARCHERS AT HARVARD MEDICAL SCHOOL, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE AND WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE. EACH YEAR, RECIPIENTS ARE SELECTED BY AN INDEPENDENT REVIEW PANEL OF ACADEMIC RESEARCHERS AND OPHTHALMOLOGISTS. THIS DISTINGUISHED PANEL AWARDS PROPOSALS THAT ALIGN WITH EVERSIGHT'S MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH MEANINGFUL SCIENTIFIC INQUISITION. 4854554 1200070 SUSTAINABLE INTERNATIONAL IMPACT EVERSIGHT WORKED WITH SURGEONS IN 27 COUNTRIES IN 2020 TO PROVIDE THE GIFT OF SIGHT THROUGH SURGICAL TISSUE PROVISION. EVERSIGHT IS FOCUSED ON MEETING THE HUMANITARIAN NEED FOR CORNEA TISSUES IN COUNTRIES WHERE SIGHT-RESTORING CORNEAL TRANSPLANT PROCEDURES WOULD OTHERWISE BE COMPLETELY UNAVAILABLE. THE BENEFICIARIES OF OUR SURGICAL TISSUE PROVISION AND COMMUNITY EYE BANK DEVELOPMENT INITIATIVES INCLUDE THE HUNDREDS OF THOUSANDS OF PEOPLE WHO SUFFER FROM EYE INJURIES AND BLINDING EYE DISEASES THAT CAN BE TREATED THROUGH CORNEAL TRANSPLANTATION. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. TO ADDRESS SYSTEMIC UNMET NEED, EVERSIGHT ACTIVELY WORKS WITH MEDICAL PROFESSIONALS, GOVERNMENTS, VISION HEALTH ORGANIZATIONS AND OTHER NGOS IN REGIONS LACKING EYE BANKS AND INFRASTRUCTURE, INCLUDING THE MIDDLE EAST, PAKISTAN AND SOUTH KOREA. WITH PROVEN EYE BANKING AND TECHNICAL TRAINING PRACTICES-AND HAVING PLAYED A PART IN THE ELIMINATION OF THE U.S. CORNEA TRANSPLANT WAITING LIST-EVERSIGHT UNIQUELY QUALIFIED TO WORK WITH COUNTRIES LACKING TRANSPLANT PROGRAMS TO HELP THEM ESTABLISH A NATIONAL NETWORK FOR EYE BANKING AND CORNEA DONATION WITH CULTURALLY APPROPRIATE DONATION MODELS AND STATE-OF-THE-ART CLINICAL CAPABILITIES. EIGHTY-NINE PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. IN 2019, EVERSIGHT WORKED WITH PAKISTAN TO OPEN ITS FIRST STATE-OF-THE-ART EYE BANKS AS PART OF A NEW NATIONAL EYE BANKING NETWORK. THE PANDEMIC SUSPENDED MOST OF OUR PLANNED WORK FOR 2020 TO HELP PAKISTAN DEVELOP ITS EYE BANKING AND COMMUNITY DONATION PROGRAM. DESPITE THE CHALLENGES OF THE PANDEMIC, THE NEW AL SHIFA EYE BANK IN RAWALPINDI WORKED WITH ITS FIRST EVER LOCAL EYE TISSUE DONOR IN JULY 2020. WE COLLABORATED WITH AL SHIFA STAFF ON OPTIMIZING DONOR FAMILY AND RECIPIENT COMMUNICATIONS, AND SUPPORTED THEIR FIRST-EVER PUBLIC OUTREACH CAMPAIGN. THE WORK CONTINUES-AND IT HAS GENERATED A NATIONAL MOVEMENT FOR ORGAN, TISSUE AND EYE DONOR REGISTRATION LED BY LOCAL PROFESSIONALS WHO TIRELESSLY EDUCATE AND ADVOCATE FOR THE GIFT OF SIGHT. BLINDING EYE DISEASES AFFECT HUNDREDS OF MILLIONS WORLDWIDE. GLOBALLY, AN ESTIMATED 285 MILLION PEOPLE ARE VISUALLY IMPAIRED-MANY WITH TREATABLE CONDITIONS, BUT WITHOUT ACCESS TO CARE. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, LET ALONE WORK TO PROVIDE FOR THEIR FAMILIES. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE IN THEIR COMMUNITIES. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. WHILE PROVIDING FOR IMMEDIATE GLOBAL CORNEA TRANSPLANT NEEDS WITH U.S. DONOR TISSUE, EVERSIGHT CONTINUES TO EMPOWER INTERNATIONAL COMMUNITIES TO TAKE MEANINGFUL, SUSTAINABLE STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL. 15452538 true true false false false false false false false true true false false true true false false true false false false false false false true false false false false true false false false false false false false false true false false false false true false false false true 30 0 true 176 true false false false false false true true false false false false false false false false X 11 11 false false false false false false false true true false false true true true true true true true true false MI X JULIE COLLINS 7347802119 3985 RESEARCH PARK DR ANN ARBOR MI 48108 DAVID BOSCH PRESIDENT & 50.00 X 261757 0 71507 MICHAEL O'KEEFE COO 50.00 X 184030 0 51638 JULIE COLLINS CFO 40.00 7.50 X 187675 0 52564 MICHAEL TITUS VP CLINICAL 50.00 X 150924 0 53576 TERESA CLARK VP PHILANTHR 50.00 X 100130 0 45395 DIANE HOLLINGSWORTH PRESIDENT & 50.00 X 172568 0 45467 JAROLD ANDERSON CHAIR 1.00 X X 0 0 0 PATTY JO HERNDON VICE CHAIR 1.00 X X 0 0 0 GARY BABCOCK TREASURER 1.00 X X 0 0 0 KATHY L ZELENOCK SECRETARY 1.00 X 0 0 0 RASHID L BASHSHUR PH D IMMEDIATE PA 1.00 1.00 X X 0 0 0 SHAHZAD MIAN MD MEDICAL DIRE 1.00 X 0 0 0 DANIELLE E D'ARCY DIRECTOR 1.00 X 0 0 0 ALAN DANINHIRSCH DIRECTOR 1.00 X 0 0 0 MAHMOUD N GHAZZI MD PHD DIRECTOR 1.00 X 0 0 0 JONATHAN LASS MD DIRECTOR 1.00 X 0 0 0 CAROLYN M WELSH DIRECTOR 1.00 X 0 0 0 CATHERINE MCCLORY DIR. COMPLIA 50.00 X 127223 0 29505 INDU VADAKKEPATTATH DATA SCI. & 50.00 X 123154 0 27062 ANDREA MEDRANO DIR. HUMAN R 50.00 X 111932 0 28990 KIMBERLY MCCULLOUGH DIR. MARKETI 50.00 X 100078 0 28176 ONKAR SAWANT DIR. RESEARC 50.00 X 107526 0 24331 1626997 458211 11 true true false 13730 658640 198142 672370 EYE TISSUE FEES 621500 18344354 18344354 INTERCOMPANY CHARGES 621500 1410540 1410540 OTHER REVENUE 621500 94848 94848 19849742 142247 142247 4491516 1480000 4284206 1375895 207310 104105 311415 311415 28087 13730 6742 21345 21345 20997119 19849742 475007 1043967 235668 662774 145525 333264 333264 7285145 5260442 1739015 285688 434861 316878 102075 15908 1172447 889417 255190 27840 649032 423584 195431 30017 9024 9024 38935 38935 63687 63687 265167 135713 129454 51213 39067 9942 2204 1589817 1177279 351146 61392 53396 36364 14638 2394 34777 11655 22050 1072 994 994 202161 149667 44676 7818 141855 105020 31349 5486 CLINICAL LAB & TECH EXP 6022150 6022150 MISCELLANEOUS 287417 6122 281193 102 EQUIPEMENT RENTAL & MAINT 220491 163237 48727 8527 LICENSE AND REGISTRATIONS 163293 121522 35652 6119 410472 358753 10546 41173 20473565 15452538 4379762 641265 3302118 4492241 146130 1574861 48410 20000 2570865 3061620 52836 84373 16321009 8730140 9536161 7590869 6599186 7895493 11719649 12063280 33975355 36782737 1925490 1469151 55485 34333 349000 2246600 18552121 18700616 20882096 22450700 X 12862787 14153738 230472 178299 13093259 14332037 33975355 36782737 X 523554 715224 X false true X true false X 8082 332911 840439 1197972 672370 3051774 17098627 10344492 21135494 21313494 19849742 89741849 17106709 10677403 21975933 22511466 20522112 92793623 25000 25000 28750 78750 8766065 8766065 25000 25000 8794815 8844815 83948808 168468 84679 171063 246808 142247 813265 168468 84679 171063 246808 142247 813265 20345 20345 27557 27557 17302734 10762082 22146996 22758274 20684704 93654790 0.89640 0.98260 0.01000 0.01000 X PART III, LINE 12 MISCELLANEOUS 27,557 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 179087 179087 179087 179087 179087 179087 174087 5000 179087 174087 174087 0.49000 0.51000 false false 7364420 693140 6671280 2061408 1628990 432418 1172949 845614 327335 5722232 5562396 159836 7590869 RECEIVABLE FROM RELATED ENTITY 11902009 DEPOSIT 161271 12063280 PAYABLE TO RELATED ENTITY 11599103 CAPITAL LEASE 7101513 18700616 21655398 715224 6742 721966 20933432 63687 63687 20997119 20416620 6742 6742 20409878 63687 63687 20473565 SCHEDULE D, PAGE 2, PART V, LINE 4 THE PURPOSE OF THE GIFT OF HOPE EYE AND VISION RESEARCH ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S GIFT OF HOPE EYE AND VISIONS RESEARCH PROGRAM. THE PURPOSE OF THE GIFT OF SIGHT CHARITABLE ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S PROGRAM WHICH WAIVES TISSUE PROCESSING FEES, OR REDUCES THE FEE FOR PATIENTS WHO ARE UNABLE TO PAY THE FULL AMOUNT. THE PURPOSE OF THE COMMUNITY EDUCATION ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S COMMUNITY EDUCATION PROGRAM. SCHEDULE D, PAGE 4, PART XI, LINE 2D SPECIAL EVENTS EXPENSES 6,742 SCHEDULE D, PAGE 4, PART XII, LINE 2D SPECIAL EVENTS EXPENSES 6,742 GOLF OUTING 31887 9154 22733 233 2042 SIP & SUPPORT 9930 4576 5354 4467 41817 13730 28087 233 4467 2042 6742 21345 X X X false false false false false false false false false DAVID BOSCH PRESIDENT & CEO 261757 15277 56230 333264 MICHAEL O'KEEFE COO 184030 11294 40344 235668 JULIE COLLINS CFO 187675 12220 40344 240239 MICHAEL TITUS VP CLINICAL SERVICES 150924 11199 42377 204500 DIANE HOLLINGSWORTH PRESIDENT & CEO 172568 10640 34827 218035 CATHERINE MCCLORY DIR. COMPLIANCE & QC 127223 8497 21008 156728 INDU VADAKKEPATTATH DATA SCI. & APP MGR. 123154 8380 18682 150216 X VARIOUS 47 97502 FMV X SOFTWARE 1 100000 FMV X GIFT CARDS 6 640 FMV false false false FORM 990 - ORGANIZATION'S MISSION EVERSIGHT'S MISSION IS TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. BLINDING EYE DISEASES AFFECT 80 MILLION AMERICANS. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, DRIVE TO WORK OR READ THE NEWSPAPER ON A SUNDAY MORNING. THEIR VISION LOSS RESULTS IN AN ECONOMIC IMPACT OF 51.4 BILLION EVERY YEAR IN THE UNITED STATES ALONE. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL MOTHERS CAN SEE THEIR CHILDREN AND ALL CHILDREN CAN GROW UP TO LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. TO MAKE VISION A REALITY FOR ALL, EVERSIGHT CONTINUOUSLY WORKS TO EXPAND ITS REACH, CONNECT MORE EFFECTIVELY WITH COMMUNITIES IN NEED AND PROVIDE THE GIFT OF SIGHT TO EVERYONE. FORM 990, PAGE 1, PART I, LINE 6 VOLUNTEERS PROVIDE VARIOUS TYPES OF SERVICES, INCLUDING LEADERSHIP, THROUGH OUR BOARD OF DIRECTORS (NATIONAL), AND OUR SERVICE AREA ADVISORY BOARDS. WE ALSO WORK WITH MEMBERS OF THE LIONS CLUB IN MICHIGAN AND THROUGHOUT OUR SERVICE AREAS TO SHARE INFORMATION ABOUT EVERSIGHT AND EYE DONATION, AND TO GATHER INTEL AND FACILITATE MEANINGFUL CONNECTIONS IN THE LOCAL COMMUNITIES WE SERVE. VOLUNTEERS HELP PLAN EVENTS SUCH AS OUR ILLINOIS GIFT OF SIGHT CHARITY EVENT, AND OUR MICHIGAN-BASED GIFT OF SIGHT GOLF CLASSIC, AND SERVE AS REPRESENTATIVES AT DONOR FAMILY GATHERINGS AND OTHER EVENTS. FORM 990, PAGE 2, PART III, LINE 4A RESORING SIGHT IN 2020, EVERSIGHT PROVIDED THE GIFT OF SIGHT TO MORE THAN 6,500 PEOPLE ACROSS THE UNITED STATES AND AROUND THE WORLD. EVERSIGHT'S WORK BEGAN IN 1947 WITH THE ESTABLISHMENT OF THE FOURTH EYE BANK IN THE UNITED STATES, THEN KNOWN AS THE ILLINOIS EYE-BANK. OVER TIME, NONPROFIT EYE BANKS WERE ESTABLISHED IN EVERY STATE TO MEET THE CRITICAL DEMAND FOR CORNEAL TISSUE TO TREAT PREVENTABLE BLINDNESS. IN 1985, THE ILLINOIS EYE-BANK AND MICHIGAN EYE-BANK FORMED A PARTNERSHIP- ONE THAT WOULD EARN A REPUTATION FOR CLINICAL EXCELLENCE MADE POSSIBLE BY SOME OF THE FINEST MEDICAL DIRECTORS, STAFF AND BOARD MEMBERS IN THE EYE BANKING FIELD. THE SUCCESS OF THE ORGANIZATION ATTRACTED AFFILIATIONS WITH OTHER REGIONAL EYE BANKS FORMING ONE OF THE LARGEST NETWORKS OF EYE BANKS IN THE U.S. IN 2015, THE NETWORK BECAME KNOWN AS EVERSIGHT, ALL WORKING TOGETHER AS A UNIFIED OPERATION TO DELIVER THE HIGHEST QUALITY SERVICES TO SURGEONS AND THEIR PATIENTS AND TO CONTINUE TO GROW OUR IMPACT AROUND THE WORLD. EVERSIGHT FACED CHALLENGES IN 2020 AND SAW THEM THROUGH TO SERVE OUR SURGEONS, THEIR PATIENTS AND DONOR FAMILIES. ON MARCH 18, 2020, U.S. CORNEA TRANSPLANTS WERE IMMEDIATELY HALTED DUE TO THE PANDEMIC. NO ONE KNEW HOW LONG IT WOULD LAST, BUT WITH SACRIFICE, INNOVATION AND STEADFAST DETERMINATION, WE KEPT HOPE IN SIGHT. AS THE VIRUS RAPIDLY SPREAD, NO ONE KNEW WHEN TRANSPLANTS MIGHT RESUME AND THE FINANCIAL IMPACT WAS IMMEDIATE. PROVIDING FOR CORNEA TRANSPLANTATION ACCOUNTS FOR 94 PERCENT OF EVERSIGHT'S OPERATING REVENUE, AND LIKE MANY NONPROFITS, WE CANCELED FUNDRAISERS WE COUNT ON TO SUPPORT OUR WORK. THAT INCLUDED OUR ANNUAL GALA, OUR LARGEST ANNUAL FUNDRAISER TO HELP LOW-INCOME PATIENTS. MEANWHILE, THE PANDEMIC WAS ELIMINATING JOBS AND HEALTH INSURANCE COVERAGE AT HISTORIC RATES ACROSS THE COUNTRY. EVEN WITH NO REVENUE COMING IN, WE DEVELOPED NEW PROTOCOLS, TESTING, TRAINING AND READINESS TO MEET THE DEMAND ONCE TRANSPLANTS COULD RESUME. IN JUNE 2020, WE WENT ABOVE AND BEYOND REGULATORY GUIDANCE AND BEGAN TESTING POTENTIAL SURGICAL TISSUE DONORS FOR SARS-COV-2. THE TEAM'S EXPERTISE AND OUR RIGOROUS STANDARDS HELPED ENSURE PATIENT SAFETY AND THE SAFETY OF DONORS' GIFTS OF TISSUE FOR TRANSPLANTATION, ONCE TRANSPLANTS COULD RESUME. IN THIS NEW PHYSICALLY DISTANCED WORLD, WE QUICKLY DEVELOPED AND BEGAN OFFERING VIRTUAL WEBINARS TO HELP SURGEONS STAY ON TOP OF EVOLVING TECHNOLOGY AND COVID-19 SCIENCE AND SAFETY. EVERSIGHT BECAME THE FIRST EYE BANK TO DEVELOP VIRTUAL WET LAB TRAINING FOR SURGEONS TO PRACTICE THEIR SURGICAL TECHNIQUES. WE PROVIDED THE TECHNOLOGY FOR SURGEONS-WHEREVER THEY ARE IN THE WORLD-TO COME TOGETHER ONLINE AND PRACTICE WITH INDIVIDUALIZED REAL-TIME GUIDANCE FROM LEADING SURGEON INSTRUCTORS. MORE THAN 640 SURGEONS AND OTHER CLINICIANS RECEIVED TRAINING THROUGH EVERSIGHT IN 2020, MORE THAN DOUBLING OUR IMPACT OVER ANY PRIOR YEAR. FORM 990, PAGE 2, PART III, LINE 4B FINDING A CURE IN THE PURSUIT TO ELIMINATE BLINDING EYE DISEASES, EVERSIGHT ESTABLISHED THE EVERSIGHT CENTER FOR VISION AND EYE BANKING RESEARCH IN CLEVELAND, OHIO, TO PROVIDE LEADING OPHTHALMOLOGY RESEARCHERS WITH THE RESOURCES THEY NEED TO FIND CURES AND TREATMENTS FOR EYE DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND GLAUCOMA. EVERSIGHT PROVIDED MORE THAN 2,600 TISSUES FOR RESEARCH AND EDUCATION PURPOSES IN 2020. OUR IN-HOUSE RESEARCH TEAM ALSO PROVIDED EVERSIGHT PARTNERS WITH VALUABLE RESEARCH AND DEVELOPMENT SERVICES, AND PIONEERED NEW EYE BANKING PRACTICES, INCLUDING CRITICAL CLINICAL ADAPTATIONS FOR TISSUE SAFETY DURING THE PANDEMIC. OUR RESEARCH AND CLINICAL LEADERSHIP AND STAFF ARE HIGHLY INVOLVED PRIMARY AND CO-INVESTIGATORS, PERFORMING RESEARCH AND AUTHORING PUBLICATIONS THAT EXPAND THE BOUNDARIES OF VISION SCIENCE, KNOWLEDGE AND POSSIBILITY. EVERSIGHT PRODUCED THE RESEARCH THE WORLD NEEDED IN 2020, INVESTIGATING IF SARS-COV-2 IS PRESENT IN EYE TISSUE. OUR WORK TOOK PLACE IN CLEVELAND, CHICAGO, ANN ARBOR AND IN NEW JERSEY-ALL HEAVILY IMPACTED BY COVID-19-WITH RESEARCH PARTNERS AT CHICAGO CORNEA CONSULTANTS AND RUSH UNIVERSITY, KELLOGG EYE CENTER AND THE UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, AND WAYNE STATE UNIVERSITY. BY OCTOBER 2020, OUR FINDINGS SHOWED A SMALL BUT NOTEWORTHY PREVALENCE OF SARS-COV-2 IN OCULAR TISSUES FROM INDIVIDUALS WHO DIED FROM COVID-19. OUR RESEARCH CONTINUES FOR ALL THOSE IN NEED OF SAFE SIGHT-RESTORING TRANSPLANTS AND FOR ALL THOSE AWAITING A CURE FOR NON- CORNEAL BLINDNESS. EVERSIGHT HAS A LONGSTANDING TRACK RECORD OF RESEARCH AND DEVELOPMENT, TO DATE AWARDING MORE THAN 4 MILLION IN GRANTS THAT STIMULATE PIONEERING CLINICAL AND BASIC SCIENCE RESEARCH AIMING TO DEVELOP NEW WAYS TO RESTORE SIGHT, PREVENT BLINDNESS AND ULTIMATELY HELP PATIENTS LIVE LIFE TO THE FULLEST. SINCE 1980, OUR EYE & VISION RESEARCH GRANT PROGRAM HAS SUPPORTED RESEARCHERS AT LEADING ACADEMIC MEDICAL INSTITUTIONS INCLUDING HARVARD, TUFTS, CLEVELAND CLINIC, CASE WESTERN RESERVE, UNIVERSITY OF MICHIGAN, NORTHWESTERN AND MORE. BY DESIGN, EVERSIGHT'S GRANT PROGRAM PROVIDES CRITICAL, EARLY-STAGE FUNDING THAT IS INTENDED TO DRIVE FOUNDATIONAL RESEARCH AND DISCOVERY. MANY OF THESE PROJECTS HAVE STIMULATED LARGER-SCALE STUDIES AND WON FURTHER FINANCIAL SUPPORT FROM THE NATIONAL INSTITUTES OF HEALTH. IN THE 2020-2021 FUNDING CYCLE, EVERSIGHT AWARDED GRANTS TO ADVANCE STUDIES ON TRANSPLANT GRAFT REJECTION, SARS-COV-2 AND THE EYE, FUCHS DYSTROPHY, DRY EYE AND NOVEL CORNEA THERAPIES, LED BY RESEARCHERS AT HARVARD MEDICAL SCHOOL, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE AND WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE. EACH YEAR, RECIPIENTS ARE SELECTED BY AN INDEPENDENT REVIEW PANEL OF ACADEMIC RESEARCHERS AND OPHTHALMOLOGISTS. THIS DISTINGUISHED PANEL AWARDS PROPOSALS THAT ALIGN WITH EVERSIGHT'S MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH MEANINGFUL SCIENTIFIC INQUISITION. FORM 990, PAGE 2, PART III, LINE 4C SUSTAINABLE INTERNATIONAL IMPACT EVERSIGHT WORKED WITH SURGEONS IN 27 COUNTRIES IN 2020 TO PROVIDE THE GIFT OF SIGHT THROUGH SURGICAL TISSUE PROVISION. EVERSIGHT IS FOCUSED ON MEETING THE HUMANITARIAN NEED FOR CORNEA TISSUES IN COUNTRIES WHERE SIGHT-RESTORING CORNEAL TRANSPLANT PROCEDURES WOULD OTHERWISE BE COMPLETELY UNAVAILABLE. THE BENEFICIARIES OF OUR SURGICAL TISSUE PROVISION AND COMMUNITY EYE BANK DEVELOPMENT INITIATIVES INCLUDE THE HUNDREDS OF THOUSANDS OF PEOPLE WHO SUFFER FROM EYE INJURIES AND BLINDING EYE DISEASES THAT CAN BE TREATED THROUGH CORNEAL TRANSPLANTATION. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. TO ADDRESS SYSTEMIC UNMET NEED, EVERSIGHT ACTIVELY WORKS WITH MEDICAL PROFESSIONALS, GOVERNMENTS, VISION HEALTH ORGANIZATIONS AND OTHER NGOS IN REGIONS LACKING EYE BANKS AND INFRASTRUCTURE, INCLUDING THE MIDDLE EAST, PAKISTAN AND SOUTH KOREA. WITH PROVEN EYE BANKING AND TECHNICAL TRAINING PRACTICES-AND HAVING PLAYED A PART IN THE ELIMINATION OF THE U.S. CORNEA TRANSPLANT WAITING LIST-EVERSIGHT UNIQUELY QUALIFIED TO WORK WITH COUNTRIES LACKING TRANSPLANT PROGRAMS TO HELP THEM ESTABLISH A NATIONAL NETWORK FOR EYE BANKING AND CORNEA DONATION WITH CULTURALLY APPROPRIATE DONATION MODELS AND STATE-OF-THE-ART CLINICAL CAPABILITIES. EIGHTY-NINE PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. IN 2019, EVERSIGHT WORKED WITH PAKISTAN TO OPEN ITS FIRST STATE-OF-THE-ART EYE BANKS AS PART OF A NEW NATIONAL EYE BANKING NETWORK. THE PANDEMIC SUSPENDED MOST OF OUR PLANNED WORK FOR 2020 TO HELP PAKISTAN DEVELOP ITS EYE BANKING AND COMMUNITY DONATION PROGRAM. DESPITE THE CHALLENGES OF THE PANDEMIC, THE NEW AL SHIFA EYE BANK IN RAWALPINDI WORKED WITH ITS FIRST EVER LOCAL EYE TISSUE DONOR IN JULY 2020. WE COLLABORATED WITH AL SHIFA STAFF ON OPTIMIZING DONOR FAMILY AND RECIPIENT COMMUNICATIONS, AND SUPPORTED THEIR FIRST-EVER PUBLIC OUTREACH CAMPAIGN. THE WORK CONTINUES-AND IT HAS GENERATED A NATIONAL MOVEMENT FOR ORGAN, TISSUE AND EYE DONOR REGISTRATION LED BY LOCAL PROFESSIONALS WHO TIRELESSLY EDUCATE AND ADVOCATE FOR THE GIFT OF SIGHT. BLINDING EYE DISEASES AFFECT HUNDREDS OF MILLIONS WORLDWIDE. GLOBALLY, AN ESTIMATED 285 MILLION PEOPLE ARE VISUALLY IMPAIRED-MANY WITH TREATABLE CONDITIONS, BUT WITHOUT ACCESS TO CARE. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, LET ALONE WORK TO PROVIDE FOR THEIR FAMILIES. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE IN THEIR COMMUNITIES. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. WHILE PROVIDING FOR IMMEDIATE GLOBAL CORNEA TRANSPLANT NEEDS WITH U.S. DONOR TISSUE, EVERSIGHT CONTINUES TO EMPOWER INTERNATIONAL COMMUNITIES TO TAKE MEANINGFUL, SUSTAINABLE STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL. FORM 990, PAGE 6, PART VI, LINE 11B THE 990 IS REVIEWED BY THE CEO AND CFO PRIOR TO FILING. COMPLETED 990 IS PROVIDED VIA E-MAIL TO ALL BOARD MEMBERS FOR COMMENTS AND QUESTIONS PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 12C THE POLICY IS REVIEWED DURING NEW EMPLOYEE ORIENTATION AND ANNUALLY WITH THE ENTIRE STAFF AND BOARD OF DIRECTORS. ANY POTENTIAL CONFLICTS OF INTEREST ARE REVIEWED BY SENIOR STAFF UPON DISCOVERY. FORM 990, PAGE 6, PART VI, LINE 15A A PERFORMANCE REVIEW IS CONDUCTED BY THE BOARD HR COMMITTEE WITH CEO; MERIT INCREASE IS RECOMMENDED BY THE HR COMMITTEE AND APPROVED BY THE BOARD. THE CEO IS NOT PART OF COMPENSATION DISCUSSION AND CEO DOES NOT PARTICIPATE IN THE SELECTION OF BOARD MEMBERS. THE CEO SALARY IS COMPARED TO SALARIES OF OTHER CEO'S AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. IN 2016 THE ORGANIZATION ENGAGED THE SERVICES OF AN INDEPENDENT CONSULTANT TO CONDUCT A LEADERSHIP COMPENSATION ANALYSIS. THEIR SOURCE OF SALARY INFORMATION IS THE 990'S ISSUED BY PEER ORGANIZATIONS, MICHIGAN NONPROFIT ASSOCIATION SALARY SURVEY, PUBLISHED BUDGETS, WEB-BASED RESEARCH THROUGH FOIA SOURCES AND INDEPENDENT SALARY SURVEY DATA. FORM 990, PAGE 6, PART VI, LINE 15B PERFORMANCE REVIEW FOR OFFICERS AND KEY EMPLOYEES IS CONDUCTED BY THE EMPLOYEES' IMMEDIATE MANAGER; MERIT INCREASES ARE RECOMMENDED BY THE MANAGER AND APPROVED BY THE CEO. SALARIES OF OFFICERS AND KEY EMPLOYEES ARE COMPARED TO SALARIES OF OTHER SIMILAR POSITIONS AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. A REPORT IS PROVIDED TO THE HR COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. IN 2016 THE ORGANIZATION ENGAGED THE SERVICES OF AN INDEPENDENT CONSULTANT TO CONDUCT A LEADERSHIP COMPENSATION ANALYSIS. THEIR SOURCE OF SALARY INFORMATION IS THE 990'S ISSUED BY PEER ORGANIZATIONS, MICHIGAN NONPROFIT ASSOCIATION SALARY SURVEY, PUBLISHED BUDGETS, WEB-BASED RESEARCH THROUGH FOIA SOURCES AND INDEPENDENT SALARY SURVEY DATA. FORM 990, PAGE 6, PART VI, LINE 19 GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9 SPECIAL EVENTS EXPENSES 6,742 SPECIAL EVENTS EXPENSES -6,742 EVERSIGHT INTERNATIONAL 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 471671769 EYE BANK MI 3 10 EVERSIGHT EVERSIGHT true EVERSIGHT NEW JERSEY 77 BRANT AVE SUITE 100 CLARK NJ 07066 203345087 EYE BANK NJ 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT MICHIGAN 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 273107692 EYE BANK MI 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT ILLINOIS 547 WEST JACKSON BLVD SUITE 600 CHICAGO IL 60661 273107617 EYE BANK IL 3 7 EVERSIGHT EVERSIGHT true MIDWIRE SYSTEMS 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 383557111 SOFTWARE MI 3 10 EVERSIGHT EVERSIGHT true EVERSIGHT OHIO 6700 EUCLID AVE SUITE 101 CLEVELAND OH 44103 455111431 EYE BANK OH 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT CONNECTICUT 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 475113503 EYE BANK CT 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT KOREA LLC 145 A 1638 TEHRAN-RO GUMCHEONGU SEOUL GUMCHEON-GU SEOUL KS EYE BANK KS EVER INT EVERSIGHT INTERNATIONAL C CORP false false false false false false false false false false false false true false false true false false false false EVERSIGHT INTERNATIONAL 274622 O 324440 COST EVERSIGHT INTERNATIONAL 231250 L 1086100 COST